UPCOMING SESSIONS in ET
Wed, Apr 29, 2026
10:00 – 11:00 PM UTC
ATTR-CM how do I know my treatment is working? Rebecca Hung MD Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 29, 2026 · 10:00 – 11:00 PM UTC
ATTR-CM how do I know my treatment is working?
Rebecca Hung MD
Click To Register
View all sessions

Drug Development

Eidos Therapeutics - Linkedin
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is…
Read more
BSIM Therapeutics - Linkedin
BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…
Read more
SOM Biotech - Linkedin
SOM Biotech is a clinical-stage drug discovery and development company based in Barcelona, Spain, with an office in the US, focused on repurposing drugs for CNS…
Read more
Prothena Corporation PLC - Linkedin
Prothena Corporation plc is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally…
Read more
Ionis Pharmaceuticals, Inc. - Linkedin
As the leader in RNA-targeted drug discovery and development, Ionis has created an efficient, broadly applicable, proprietary antisense technology platform with the…
Read more
Subscribe to